RCT: Supplementing milk with enteral recombinant human insulin in preterm infants is safe and results in earlier achievement of full enteral feeding.
6 Mar, 2022 | 23:58h | UTCEfficacy and Safety of Enteral Recombinant Human Insulin in Preterm Infants: A Randomized Clinical Trial – JAMA Pediatrics (link to abstract – $ for full-text)
Commentary: Enteral insulin reduces the duration of feeding intolerance in preterm infants – MedPage Today (free registration required)
Commentary on Twitter
Study findings support the use of rh insulin as a supplement to human milk and preterm formula. https://t.co/IA2MuIMJdc
— JAMA Pediatrics (@JAMAPediatrics) February 28, 2022